| |
|
|
Company
|
|
|
|
|
|
|
Set up
|
|
Team
|
|
Customers
|
|
Technology
|
|
|
|
|
|
|
|
|
|
Current Researchs
|
|
Services / Products
|
|
Screening Services
|
|
Endothelial Cells Supply
|
|
Contacts
|
|
Ask For Information
|
|
|
|
|
|
|
|
|
SITE UNDER CONSTRUCTION
|
Dehouck
MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, Tillement
JP.
Drug transfer across the blood-brain barrier: correlation between
in vitro and in vivo models.
J Neurochem. 1992 May;58(5):1790-7.
Dehouck
B, Dehouck MP, Fruchart JC, Cecchelli R.
Upregulation of the low density lipoprotein receptor at the blood-brain
barrier: intercommunications between brain capillary endothelial
cells and astrocytes.
J Cell Biol. 1994 Jul;126(2):465-73.
Descamps
L, Dehouck MP, Torpier G, Cecchelli R.
Receptor-mediated transcytosis of transferrin through blood-brain
barrier endothelial cells.
Am J Physiol. 1996 Apr;270(4 Pt 2):H1149-58.
Dehouck
B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R.
A new function for the LDL receptor: transcytosis of LDL across
the blood-brain barrier.
J Cell Biol. 1997 Aug 25;138(4):877-89.
Dehouck M.P., Dehouck B., Schluep C., Lemaire M., Cecchelli R.
Drug transport to the brain : comparison between in vitro and in
vivo models of the blood-brain barrier.
Eur. J. Pharm. Sci. 1995 ;357-365.
Fenart
L, Buee-Scherrer V, Descamps L, Duhem C, Poullain MG, Cecchelli
R, Dehouck MP.
Inhibition of P-glycoprotein: rapid assessment of its implication
in blood-brain barrier integrity and drug transport to the brain
by an in vitro model of the blood-brain barrier.
Pharm Res. 1998 Jul;15(7):993-1000.
Cecchelli
R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer V V, Duhem C,
Lundquist S, Rentfel M, Torpier G, Dehouck MP.
In vitro model for evaluating drug transport across the blood-brain
barrier.
Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):165-178.
Fenart
L, Casanova A, Dehouck B, Duhem C, Slupek S, Cecchelli R, Betbeder
D.
Evaluation of effect of charge and lipid coating on ability of 60-nm
nanoparticles to cross an in vitro model of the blood-brain barrier.
J Pharmacol Exp Ther. 1999 Dec;291(3):1017-22.
Olivier
JC, Fenart L, Chauvet R, Pariat C, Cecchelli R, Couet W.
Indirect evidence that drug brain targeting using polysorbate 80-coated
polybutylcyanoacrylate nanoparticles is related to toxicity.
Pharm Res. 1999 Dec;16(12):1836-42.
Fillebeen
C, Descamps L, Dehouck MP, Fenart L, Benaissa M, Spik G, Cecchelli
R, Pierce A.
Receptor-mediated transcytosis of lactoferrin through the blood-brain
barrier.
J Biol Chem. 1999 Mar 12;274(11):7011-7.
Carpentier
M, Descamps L, Allain F, Denys A, Durieux S, Fenart L, Kieda C,
Cecchelli R, Spik G.
Receptor-mediated transcytosis of cyclophilin B through the blood-brain
barrier.
J Neurochem. 1999 Jul;73(1):260-70.
Lundquist
S, Renftel M, Brillault J, Fenart L, Cecchelli R, Dehouck MP.
Prediction of drug transport through the blood-brain barrier in
vivo: a comparison between two in vitro cell models.
Pharm Res. 2002 Jul;19(7):976-81.
|
|
|